3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
6
Pancreatic Neoplasms
5
Colorectal Neoplasms
4
Rectal Neoplasms
3
Colonic Neoplasms
3
Agnosia
3
Liver Neoplasms
2
Stomach Neoplasms
1
Pain
1
Neuralgia
1
Neoplasms
1
Intestinal Perforation
1
Intestinal Diseases
1
Inflammatory Bowel Diseases
1
Ileus
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Duodenal Neoplasms
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Diverticulitis
1
Digestive System Diseases
1
Crohn Disease
1
Constipation
1
Interventions
Sutures
1
Surveys and Questionnaires
1
Surgical Instruments
1
Ringer's Lactate
1
Proctocolectomy, Restorative
1
Photoplethysmography
1
Phlebotomy
1
Lysine Acetyltransferase 5
1
Laparoscopy
1
Infliximab
1
Hydroxyethyl Starch Derivatives
1
Educational Status
1
Dexamethasone
1
Calcium Dobesilate
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Crohn Disease
×
Bupivacaine
×
Gastrointestinal
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts